KENNEDY SPACE CENTER, Fla., February 15, 2022 (Northrop Grumman PR) – Northrop Grumman will launch a variety of critical research and supplies on its upcoming 17th Commercial Resupply Services (CRS) mission to the International Space Station (ISS). The launch, which take place at NASA’s Wallops Flight Facility in Virginia, is scheduled for no earlier than February 19 at 12:40 p.m. ET.
The ISS National Laboratory is sponsoring more than 15 research and technology development payloads as part of this mission. These payloads, which represent diverse fields of study, intend to bring value to our nation through space-based research and enable a robust and sustainable market in low Earth orbit. Below highlights some of the ISS National Lab-sponsored investigations launching on Northrop Grumman CRS-17.
Selected projects to receive funding from CASIS and Boeing through the Technology in Space Prize
KENNEDY SPACE CENTER, Fla, November 2, 2021 (CASIS PR) – The Center for the Advancement of Science and Space, Inc. (CASIS) and Boeing [NYSE: BA] are awarding up to $500,000 in grants to two startup companies through the Technology in Space Prize. The startups, krtkl inc. and Oculogenex, Inc., were identified through the MassChallenge (Boston) startup accelerator program. The companies will leverage the International Space Station (ISS) National Laboratory, managed by CASIS, to further their research and technology development in low Earth orbit.
KENNEDY SPACE CENTER, Fla., October 26, 2020 (CASIS PR) – When Northrop Grumman launched its Cygnus spacecraft to the International Space Station (ISS) on October 2, 2020, it was loaded with a multitude of research and technology development investigations to be carried out onboard the orbiting laboratory.
Once Cygnus berthed with the space station three days later and its contents were unloaded by the astronauts onboard, it was time to start performing some of the science that flew on Northrop Grumman’s 14th commercial resupply services (CRS) mission.
KENNEDY SPACE CENTER, Fla. March 6, 2020 (ISS National Lab PR) – What if the next breakthrough to improve patient care on Earth came from research off of Earth—in space? Three biotechnology startups have launched research to the International Space Station (ISS) U.S. National Laboratory, tackling a broad range of patient care objectives—from next-generation diagnostic tools to drug discovery and improved devices for drug delivery.